Incyte Stock Total Asset
| INCY Stock | USD 51.92 0.43 0.82% |
Incyte fundamentals help investors to digest information that contributes to Incyte's financial success or failures. It also enables traders to predict the movement of Incyte Stock. The fundamental analysis module provides a way to measure Incyte's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Incyte stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 6.8 B | 7.1 B | |
| Intangibles To Total Assets | 0.04 | 0.05 |
Incyte | Total Asset |
Incyte Company Total Asset Analysis
Incyte's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Incyte Total Asset | 6.78 B |
Most of Incyte's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Incyte is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Incyte Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Incyte is extremely important. It helps to project a fair market value of Incyte Stock properly, considering its historical fundamentals such as Total Asset. Since Incyte's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Incyte's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Incyte's interrelated accounts and indicators.
Click cells to compare fundamentals
Incyte Total Asset Historical Pattern
Today, most investors in Incyte Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Incyte's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Incyte total asset as a starting point in their analysis.
Incyte Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Incyte Total Assets
Total Assets |
|
Based on the latest financial disclosure, Incyte has a Total Asset of 6.78 B. This is 9.81% lower than that of the Biotechnology sector and 243.25% higher than that of the Health Care industry. The total asset for all United States stocks is 76.98% higher than that of the company.
Incyte Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incyte's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incyte could also be used in its relative valuation, which is a method of valuing Incyte by comparing valuation metrics of similar companies.Incyte is currently under evaluation in total asset category among related companies.
Incyte ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Incyte's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Incyte's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Incyte Institutional Holders
Institutional Holdings refers to the ownership stake in Incyte that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Incyte's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Incyte's value.| Shares | Lsv Asset Management | 2023-12-31 | 2.7 M | Man Group Plc | 2023-12-31 | 2.4 M | Goldman Sachs Group Inc | 2023-12-31 | 2.4 M | Pictet Asset Manangement Sa | 2023-12-31 | 2.3 M | Bellevue Group Ag | 2023-12-31 | 2.2 M | Jacobs Levy Equity Management, Inc. | 2023-09-30 | 2.1 M | Northern Trust Corp | 2023-12-31 | 2 M | Norges Bank | 2023-12-31 | 2 M | Legal & General Group Plc | 2023-12-31 | 2 M | Baker Bros Advisors Lp | 2023-12-31 | 36.2 M | Blackrock Inc | 2023-12-31 | 24.3 M |
Incyte Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0646 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 8.15 B | ||||
| Shares Outstanding | 224.53 M | ||||
| Shares Owned By Insiders | 1.58 % | ||||
| Shares Owned By Institutions | 99.95 % | ||||
| Number Of Shares Shorted | 8.06 M | ||||
| Price To Earning | 19.17 X | ||||
| Price To Book | 2.33 X | ||||
| Price To Sales | 3.27 X | ||||
| Revenue | 3.7 B | ||||
| Gross Profit | 1.59 B | ||||
| EBITDA | 904.74 M | ||||
| Net Income | 597.6 M | ||||
| Cash And Equivalents | 2.72 B | ||||
| Cash Per Share | 12.24 X | ||||
| Total Debt | 38.29 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.91 X | ||||
| Book Value Per Share | 23.14 X | ||||
| Cash Flow From Operations | 496.49 M | ||||
| Short Ratio | 4.27 X | ||||
| Earnings Per Share | 2.65 X | ||||
| Price To Earnings To Growth | 0.69 X | ||||
| Target Price | 75.35 | ||||
| Number Of Employees | 2.52 K | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 11.75 B | ||||
| Total Asset | 6.78 B | ||||
| Retained Earnings | 160.38 M | ||||
| Working Capital | 3.41 B | ||||
| Current Asset | 842.38 M | ||||
| Current Liabilities | 168.01 M | ||||
| Net Asset | 6.78 B |
About Incyte Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incyte's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incyte using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incyte based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incyte Piotroski F Score and Incyte Altman Z Score analysis. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Incyte Stock analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.324 | Earnings Share 2.65 | Revenue Per Share 16.526 | Quarterly Revenue Growth 0.093 | Return On Assets 0.0646 |
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.